Keros Therapeutics

-$0.57 (-1.08%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell KROS and other stocks, options, and ETFs commission-free!

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need.

CEO
Jasbir S. Seehra
Employees
35
Headquarters
Lexington, Massachusetts
Founded
2015

KROS Key Statistics

Market Cap
1.23B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
100.18K
High Today
$53.05
Low Today
$50.43
Open Price
$53.05
Volume
120.55K
52 Week High
$88.80
52 Week Low
$25.71

KROS Earnings

-$5.11
-$3.41
-$1.70
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure